ImmunityBio
$9.28Change from previous close: −1.69%Absolute change: −$0.16
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $9.84B
- Enterprise value
- $10.71B
- Forward P/E
- -73.3
- Price/sales
- 59.3
- EV/EBITDA
- -45.5
- EV/revenue
- 64.6
Profitability and growth
- Gross margin
- 99.3%
- Operating margin
- -120.4%
- Net margin
- 0.0%
- ROA
- -30.5%
- Revenue growth (year over year)
- 93.9%
Financial health
- Total cash
- $357.37M
- Total debt
- $1.23B
- Current ratio
- 5.72
- Quick ratio
- 5.36
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $12.75
- Median price target
- $12.00
- High price target
- $15.00
- Low price target
- $12.00
- Analysts with a price target
- 4
- Forward EPS
- -$0.13
- EPS estimate, current year
- -$0.92
Shares and trading
- Beta
- 0.14
- Average volume
- 9.74M
- Shares outstanding
- 1.06B
- Float
- 406.64M
- Institutional ownership
- 19.8%
- Insider ownership
- 62.2%
- Short interest (% of float)
- 31.3%
- Short ratio (days)
- 15.1